Moreover, the genetic variant rs1061170 (p.Y402H) in CFH which is a strong risk factor for AMD seems to influence the levels of ceramides in serum, and FHL-1 variants Y402 and H402 differentially regulate the expression of ceramide synthesis genes in retinoblastoma-derived cells. This evidence concerns the gene CFH and retinoblastoma.